European study aims to unlock secrets of CMV in transplant patients

NCT ID NCT05701228

Ongoing Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jan 19, 2026 · Last updated May 15, 2026 · Updated 19 times

Summary

This study is for adults receiving a kidney, lung, liver, or heart transplant. It aims to better understand how the body interacts with cytomegalovirus (CMV) after transplant. Researchers will collect blood and tissue samples and track patients' health over time. The goal is to improve prevention and treatment of CMV, a common and serious infection in transplant recipients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Hopitel Pellegrin

Bordeaux, 33076, France
Hôpital Edouard Hériot

Lyon, 69003, France
Hôpital Foch

Suresnes, 92150, France
Hôpital LA PITIE SALPETRIERE

Paris, 75013, France
Hôpital Necker

Paris, 75015, France
Hôpital Paul Brousse

Villejuif, 94804, France
Hôpital Rangueil

Toulouse, 31059, France

Conditions

Explore the condition pages connected to this study.

CYTOMEGALOVIRUS INFECTIONS SOLID ORGAN TRANSPLANTATION SOLID-ORGAN TRANSPLANTATION